Indanone: a promising scaffold for new drug discovery against neurodegenerative disorders

被引:2
作者
Bansal, Ranju [1 ]
Singh, Ranjit [1 ]
Dutta, Tuhin Shubra [1 ]
Dar, Zahid Ahmad [1 ]
Bajpai, Ankit [1 ]
机构
[1] Panjab Univ, Univ Inst Pharmaceut Sci UIPS, Chandigarh 160014, India
关键词
indanone; Alzheimer ' s disease; Parkinson ' s disease; monoamine oxidases (MAO); acetylcholinesterase (AChE); molecular docking; TARGETING ALZHEIMERS-DISEASE; ALPHA-TETRALONE DERIVATIVES; MONOAMINE-OXIDASE; ACETYLCHOLINESTERASE INHIBITORS; ANTIINFLAMMATORY DRUGS; PHARMACOLOGICAL EVALUATION; RECEPTOR ANTAGONIST; OXIDATIVE STRESS; ISCHEMIC-STROKE; DESIGN;
D O I
10.1016/j.drudis.2024.104063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Indanone is a versatile scaffold that has a number of pharmacological properties. The successful development and ensuing approval of indanone-derived donepezil as a drug of choice for Alzheimer ' s disease attracted signi ficant scienti fic interest in this moiety. Indanones could act as small molecule chemical probes as they have strong af finity towards several critical enzymes associated with the pathophysiology of various neurological disorders. Inhibition of these enzymes elevates the levels of neuroprotective brain chemicals such as norepinephrine, serotonin and dopamine. Further, indanone derivatives are capable of modulating the activities of both monoamine oxidases (MAO-A and-B) and acetylcholinesterase (AChE), and thus could be useful in various neurodegenerative diseases. This review article presents a panoramic view of the research carried out on the indanone nucleus in the development of potential neuroprotective agents.
引用
收藏
页数:15
相关论文
共 97 条
[11]   Dopamine agonists: their role in the treatment of Parkinson's disease [J].
Brooks, DJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (06) :685-689
[12]   Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation [J].
Camps, Pelayo ;
Formosa, Xavier ;
Galdeano, Carles ;
Gomez, Tania ;
Munoz-Torrero, Diego ;
Scarpellini, Michele ;
Viayna, Elisabet ;
Badia, Albert ;
Clos, M. Victoria ;
Camins, Antoni ;
Pallas, Merce ;
Bartolini, Manuela ;
Mancini, Francesca ;
Andrisano, Vincenza ;
Estelrich, Joan ;
Lizondo, Monica ;
Bidon-Chanal, Axel ;
Luque, F. Javier .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (12) :3588-3598
[13]   Acute Ischemic Stroke: Management Approach [J].
Chugh, Chandril .
INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2019, 23 :S140-S146
[14]   Multiple sclerosis [J].
Compston, Alastair ;
Coles, Alasdair .
LANCET, 2008, 372 (9648) :1502-1517
[15]   Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors [J].
Costanzo, Paola ;
Cariati, Luca ;
Desiderio, Doriana ;
Sgammato, Roberta ;
Lamberti, Anna ;
Arcone, Rosaria ;
Salerno, Raffaele ;
Nardi, Monica ;
Masullo, Mariorosario ;
Oliverio, Manuela .
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (05) :470-475
[16]   The Contribution of Non-Neuronal Cells in Neurodegeneration: From Molecular Pathogenesis to Therapeutic Challenges [J].
D'Ambrosi, Nadia ;
Cozzolino, Mauro ;
Apolloni, Savina .
CELLS, 2022, 11 (02)
[17]   The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence [J].
Danysz, W ;
Parsons, CG .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 :S23-S32
[18]   Mitochondrial Function and Dysfunction: An Update [J].
Davis, Robert E. ;
Williams, Michael .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) :598-607
[19]   The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety [J].
de Beer, Andries D. ;
Legoabe, Lesetja J. ;
Petzer, Anel ;
Petzer, Jacobus P. .
BIOORGANIC CHEMISTRY, 2021, 114
[20]   Diabetic Neuropathies: Diagnosis and Management [J].
Deli, Gabriella ;
Bosnyak, Edit ;
Pusch, Gabriella ;
Komoly, Samuel ;
Feher, Gergely .
NEUROENDOCRINOLOGY, 2013, 98 (04) :267-280